Found 5 matching trials
Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children
PHASE2The present study is designed to evaluate in children (aged between 3 and 9...
Location
GSK Investigational Site
Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above
PHASE3Today, the leading contender for the next pandemic of influenza is H5N1, a ...
Location
GSK Investigational Site
A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children
PHASE3The purpose of this study is to assess the safety and immunogenicity of a p...
Location
GSK Investigational Site
Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)
PHASE2The aim of the study is to assess the safety \& immunogenicity of a pandemi...
Location
GSK Investigational Site
Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults
PHASE2The present study is designed to evaluate the reactogenicity and immunogeni...
Location
GSK Investigational Site